← Back to Patent Explorer
US4418058A Expired / Lapsed US ⏱️ 0.0 years remaining

Protection of lyophilized betalactams from color formation

Assignee: Shionogi and Co Ltd
•
Filing: 1981-06-12
•
Granted: 1983-11-29
•
Expires: 2001-06-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A stable preparation of a lyophilized β-lactam antibacterial containing a 7β-(α-carboxy-α-arylacetamido)-7α-methoxy-3-heterocyclic thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid (I) alkali metal salt as the antibacterial component and a sugar or sugar alcohol compound as the stabilizing agent. ##STR1## (wherein Ar is a p-hydroxyaryl group and Het is a heterocyclic group optionally substituted by an alkyl group)

Inventors

  • 👤 Eizo Hirai
  • 👤 Kazuhiro Shima

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 20:25
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/54; A61K31/542; A61K31/545; A61K9/00; A61K9/0012; A61K9/0019; A61K31/535; A61K47/00; A61K47/06; A61K47/26; A61P; A61P31/00; A61P31/04

Claims Analysis

Total Claims: 28
Claim 1
Independent Claim 144 words
A stable lyophilized antibacterial preparation containing an alkali metal salt of 7β-(α-carboxy-α-arylacetamido)-7α-methoxy-3-heterocyclic thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid of the formula ##STR3## wherein Ar is a p-hydroxyphenyl group which is unsubstituted or substituted by halogen, hydroxy, 1 to 3 C alkoxy or 1 to 3 C alkyl, and Het is a 5 to 6 membered monocyclic heterocyclic group having 3 or 4 heteroatoms selected from nitrogen, oxygen or sulfur which is unsubstituted or is substituted by 1 to 5 C alkyl as antibacterial component and 0.1 to 1.0 part per part by weight antibacterial component of a sugar or sugar alcohol compound selected from arabitol, dambonitrol, dulcitol, inositol, mannitol, ononitol, pinitol, quercitol, sequoytol, sorbitol, viburnitol, xylitol, allose, altrose, arabinose, fructose, galactose, glucose, gulose, idose, lactose, lyxose, maltose, mannose, ribose, ribulose, sedoheptulose, sorbose, sucrose, tagatose, talose and xylose as stabilizing agent for the purpose of preventing blue color formation.
Claim 2
Dependent Claim 144 words
A stable lyophilized antibacterial preparation containing an alkali metal salt of 7β-(α-carboxy-α-arylacetamido)-7α-methoxy-3-heterocyclic thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid of the formula ##STR3## wherein Ar is a p-hydroxyphenyl group which is unsubstituted or substituted by halogen, hydroxy, 1 to 3 C alkoxy or 1 to 3 C alkyl, and Het is a 5 to 6 membered monocyclic heterocyclic group having 3 or 4 heteroatoms selected from nitrogen, oxygen or sulfur which is unsubstituted or is substituted by 1 to 5 C alkyl as antibacterial component and 0.1 to 1.0 part per part by weight antibacterial component of a sugar or sugar alcohol compound selected from arabitol, dambonitrol, dulcitol, inositol, mannitol, ononitol, pinitol, quercitol, sequoytol, sorbitol, viburnitol, xylitol, allose, altrose, arabinose, fructose, galactose, glucose, gulose, idose, lactose, lyxose, maltose, mannose, ribose, ribulose, sedoheptulose, sorbose, sucrose, tagatose, talose and xylose as stabilizing agent for the purpose of preventing blue color formation.
Claim 3
Dependent Claim 19 words
A preparation claimed in claim 1 in which the Ar group of the antibacterial component is p-hydroxyphenyl or 4-hydroxy-2-fluorophenyl.
Claim 4
Dependent Claim 26 words
A preparation claimed in claim 1 in which the Het group of the antibacterial component is unsubstituted or has methyl, ethyl or isobutyl as the substituent.
Claim 5
Dependent Claim 23 words
A preparation claimed in claim 1 in which the Het group of the antibacterial component is selected from 1,2,3-triazol-4-yl, 1-methyl-5-tetrazolyl, 1,3,4-thiadiazol-2-yl and 2-methyl-1,3,4-thiadiazol-5-yl.
Claim 6
Dependent Claim 19 words
A preparation claimed in claim 1 in which the alkali metal salt is a lithium, sodium or potassium salt.
Claim 7
Dependent Claim 24 words
A preparation claimed in claim 1 in which the antibacterial component is a mixture of one or more kinds of the alkali metal salts.
Claim 8
Dependent Claim 15 words
A preparation claimed in claim 1 in which the sugar alcohol has 6 carbon atoms.
Claim 9
Dependent Claim 24 words
A preparation claimed in claim 1 in which the sugar alcohol or sugar is selected from mannitol, sorbitol, xylitol, arabinose, fructose, sorbose and xylose.
Claim 10
Dependent Claim 21 words
A preparation claimed in claim 1 in which the sugar alcohol or sugar is selected from dulcitol, inositol, glucose, and mannose.
Claim 11
Dependent Claim 13 words
A preparation claimed in claim 1 that contains mannitol as the sugar alcohol.
Claim 12
Dependent Claim 25 words
A preparation claimed in claim 1 which is prepared by freeze drying of a mixed aqueous solution containing the antibacterial component and the stabilizing agent.
Claim 13
Dependent Claim 21 words
A preparation claimed in claim 1 that contains a sodium salt of 7β-(α-carboxy-α-p-hydroxyphenylacetamido)-7α-methoxy-3-(1-methyl-5-tetrazolyl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid, 7β-(α-carboxy-α-p-hydroxyphenylacetamido)-7α-methoxy-b 3-(1,3,4-thiadiazol-2-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid, 7β-(α-carboxy-α-p-hydroxyphenylacetamido)-7α-methoxy-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylicacid or 7β-(α-(4-hydroxy-2-fluorophenyl)-α-carboxyacetamido)-7.alpha.-methoxy-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid.
Claim 14
Dependent Claim 16 words
A preparation claimed in claim 1 in which the salt is a sodium or potassium salt.
Claim 15
Dependent Claim 15 words
A preparation claimed in claim 1 in which the salt is a mono-salt or di-salt.
Claim 16
Dependent Claim 19 words
A preparation claimed in claim 1 in which the antibacterial component is a mixture of the alkali metal salts.
Claim 17
Dependent Claim 11 words
A preparation claimed in claim 1 stored in an inert gas.
Claim 18
Dependent Claim 73 words
A method for the production of a lyophilized antibacterial preparation as defined in claim 1 which comprises (1) dissolving the antibacterial component and the stabilizing agent, said component and agent being as defined in claim 1, in an injectable aqueous carrier to obtain a mixed aqueous solution; (2) cooling the solution to freezing at subzero temperature and (3) subliming the water contained in the frozen mass to obtain a non-coloring table lyophilized preparation.
Claim 19
Dependent Claim 19 words
A method claimed in claim 17 wherein the freezing and subliming are carried out in a tray or vial.
Claim 20
Dependent Claim 19 words
A method claimed in claim 17 in which the Ar group of the antibacterial component is p-hydroxyphenyl or 4-hydroxy-2-fluorophenyl.
Claim 21
Dependent Claim 26 words
A method claimed in claim 17 in which the Het group of the antibacterial component is unsubstituted or has methyl, ethyl or isobutyl as the substituent.
Claim 22
Dependent Claim 23 words
A method claimed in claim 17 in which the Het group of the antibacterial component is selected from 1,2,3-triazol-4-yl, 1-methyl-5-tetrazolyl, 1,3,4-thiadiazol-2-yl and 2-methyl-1,3,4-thiadiazol-5-yl.
Claim 23
Dependent Claim 19 words
A method claimed in claim 17 in which the alkali metal salt is a lithium, sodium or potassium salt.
Claim 24
Dependent Claim 22 words
A method claimed in claim 17 in which the antibacterial component is a mixture of one or more kinds of the salts.
Claim 25
Dependent Claim 15 words
A method claimed in claim 17 in which the sugar alcohol has 6 carbon atoms.
Claim 26
Dependent Claim 24 words
A method claimed in claim 17 in which the sugar alcohol or sugar is selected from mannitol, sorbitol, xylitol, arabinose, fructose, sorbose and xylose.
Claim 27
Dependent Claim 21 words
A method claimed in claim 17 in which the sugar alcohol or sugar is selected from dulcitol, inositol, glucose and mannose.
Claim 28
Dependent Claim 13 words
A method claimed in claim 17 in which the sugar alcohol is mannitol.

References Cited (Backward Citations)

US3993753A Cited
US4180571A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-11-28 1987-05-30 1987-11-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-11-28 1991-05-30 1991-11-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-11-28 1995-05-30 1995-11-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag